A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 31/505 (2006.01) A61K 38/17 (2006.01) C07K 16/24 (2006.01)
Patent
CA 2290021
Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed are compositions comprising a TNF.alpha. antagonist and a VEGF antagonist. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
L'invention concerne des procédés permettant de traiter et/ou d'empêcher une maladie associée au facteur de nécrose tumorale (TNF) chez un individu. L'invention concerne également des compositions contenant un antagoniste du TNF.alpha. et un antagoniste du facteur de croissance des cellules endothéliales vasculaires (VEGF). Parmi les maladies médiées par le TNF on trouve la polyarthrite rhumatoïde, la maladie de Crohn ainsi que des troubles immunologiques aigus et chroniques associés à une greffe.
Feldmann Marc
Maini Ravinder Nath
Paleolog Ewa Maria
Borden Ladner Gervais Llp
The Kennedy Institute Of Rheumatology
LandOfFree
Suppression of tumor necrosis factor alpha and vascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suppression of tumor necrosis factor alpha and vascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of tumor necrosis factor alpha and vascular... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1554441